References

1. http://MarketResearch.com/, "How Electronic Data Capture will Change Health Care and Pharmaceutical Marketing," http://www.marketresearch.com/map/prod/1204213.html (December 2005).

2. M.J. Ball, D.E. Garets, T.J. Handler, "Leveraging IT to Improve Patient Safety Methods," Methods ofInformation in Medicine, 42, 503-509 (2003).

4. D. Iberson-Hurst, "E-Source is Coming: Report of CDISC 2004 Survey (Excluding ePRO Trials)," BIO IT World (July 2005).

5. J.A. Di Masi, R.W. Hansen, H.G. Grabowski, "The Price of Innovation: New Estimates of Drug Development Costs," Journal of Health Economics, 22 (2003).

6. T. Handler et al., Healthcare Information and Management Systems Society, Electronic Health Record Committee, EHR Definition, Attributes, and Essential Requirements Version 1.0 (2003).

7. A. Garfield, Electronic Health Records in Europe: A Shared Vision for Tomorrow, Presented at the Midwest Instruction and Computing Symposium, University of Northern Iowa, Cedar Falls, Iowa, April 5-6, 2002.

8. P. Bleicher, "Integrating EHR with EDC: When Two Worlds Collide," Applied Clinical Trials, http://www.actmagazine.com/appliedclinicaltrials/ (March 2006).

9. The eClinical Forum and PhRMA EDC/eSource Taskforce, The Future Vision of Electronic Health Records as eSource for Clinical Research, Version 1.0 (September 2006).

10. Clinical Data Interchange Standard Consortium, http://www.cdisc.org/.

11. Health Level Seven, http://www.hl7.ca/.

12. Clinical Trial News, "EDC & EHR: Readers Optimistic About Future Merger," Applied Clinical Trials, 15 (12), 12 (December 2006).